The frequency of 3’ (a) and 5’ (b) defective HIV-1 proviruses at ART initiation and after 180 and 365 days of ART among individuals in the four groups (lines at median, error bars represent interquartile ranges) (c). P values comparing within group were calculated using paired two-tailed Wilcoxon test. ART only n=14, ART+3BNC117 n=14, ART+RMD n=10, ART+3BNC117+RMD n=14.
ART, antiretroviral therapy; RMD, romidepsin.